Related Experiment Video
Updated: Jun 11, 2025
06:08
Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
1.6K
Recent Advances in Allergic Rhinitis: A Narrative Review.
Megha Tidke1, Pramod T Borghare1, Piyush Pardhekar1
1Otolaryngology, Mahatama Gandhi Ayurveda College, Hospital and Research Centre, Wardha, IND.
Cureus
|October 7, 2024
Summary
Recent advancements in allergic rhinitis (AR) management include new therapies and diagnostics. This review synthesizes these developments for improved patient outcomes and quality of life in AR.
Area of Science:
- Immunology
- Allergology
- Respiratory Medicine
Background:
- Allergic rhinitis (AR) is a common chronic respiratory condition affecting quality of life.
- Recent years have seen significant progress in understanding AR's pathophysiology, diagnosis, and treatment.
Purpose of the Study:
- To provide a comprehensive overview of recent developments in allergic rhinitis.
- To synthesize key advancements in AR pathophysiology, diagnostics, and management.
Main Methods:
- This narrative review synthesizes recent research and clinical findings.
- Key areas explored include pathophysiology, diagnostics, pharmacological and non-pharmacological treatments, and digital health integration.
Main Results:
- New insights into AR pathophysiology highlight the roles of the epithelial barrier and microbiome.
- Advanced diagnostics like component-resolved diagnostics improve allergy identification.
- Novel biologics and non-pharmacological strategies offer improved symptom control, especially for refractory cases.
Conclusions:
- The field of allergic rhinitis management is rapidly evolving with ongoing research.
- Staying updated on these advances is crucial for optimizing patient care and quality of life.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
241
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
241
02:06Allergic Reactions
27.3K
Overview
27.3K
01:20Asthma: Pathogenesis and Management
363
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
363
01:17Drugs Used in Lower Respiratory Disorders: Overview
358
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
358
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
226
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
226
01:16Drugs Used in Upper Respiratory Disorders: Overview
183
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
183